BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26700341)

  • 21. CT time-attenuation washout curves of adrenal adenomas and nonadenomas.
    Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Londy F
    AJR Am J Roentgenol; 1998 Mar; 170(3):747-52. PubMed ID: 9490968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
    Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
    Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
    Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
    Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT.
    Caoili EM; Korobkin M; Francis IR; Cohan RH; Platt JF; Dunnick NR; Raghupathi KI
    Radiology; 2002 Mar; 222(3):629-33. PubMed ID: 11867777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?
    Northcutt BG; Raman SP; Long C; Oshmyansky AR; Siegelman SS; Fishman EK; Johnson PT
    AJR Am J Roentgenol; 2013 Oct; 201(4):834-9. PubMed ID: 24059372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.
    Peña CS; Boland GW; Hahn PF; Lee MJ; Mueller PR
    Radiology; 2000 Dec; 217(3):798-802. PubMed ID: 11110946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT.
    Szolar DH; Kammerhuber FH
    Radiology; 1998 May; 207(2):369-75. PubMed ID: 9577483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.
    Foti G; Faccioli N; Manfredi R; Mantovani W; Mucelli RP
    AJR Am J Roentgenol; 2010 Jun; 194(6):1484-91. PubMed ID: 20489087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed enhanced CT for differentiation of benign from malignant adrenal masses.
    Korobkin M; Brodeur FJ; Francis IR; Quint LE; Dunnick NR; Goodsitt M
    Radiology; 1996 Sep; 200(3):737-42. PubMed ID: 8756924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidental adrenal lesions detected on enhanced abdominal dual-energy CT: can the diagnostic workup be shortened by the implementation of virtual unenhanced images?
    Botsikas D; Triponez F; Boudabbous S; Hansen C; Becker CD; Montet X
    Eur J Radiol; 2014 Oct; 83(10):1746-51. PubMed ID: 25064663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal metastases: early biphasic contrast-enhanced CT findings with emphasis on differentiation from lipid-poor adrenal adenomas.
    Zhu F; Zhu X; Shi H; Liu C; Xu Z; Shao M; Tian F; Wang J
    Clin Radiol; 2021 Apr; 76(4):294-301. PubMed ID: 33509608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pheochromocytomas Versus Adenoma: Role of Venous Phase CT Enhancement.
    Mohammed MF; ElBanna KY; Ferguson D; Harris A; Khosa F
    AJR Am J Roentgenol; 2018 May; 210(5):1073-1078. PubMed ID: 29570377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold?
    Ho LM; Paulson EK; Brady MJ; Wong TZ; Schindera ST
    AJR Am J Roentgenol; 2008 Jul; 191(1):234-8. PubMed ID: 18562751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas?
    Szolar DH; Kammerhuber F
    Radiology; 1997 Feb; 202(2):517-21. PubMed ID: 9015083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI.
    Wu YW; Tan CH
    Abdom Radiol (NY); 2016 Jun; 41(6):1170-7. PubMed ID: 26830419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidental adrenal lesions: Accuracy of quadriphasic contrast enhanced computed tomography in distinguishing adenomas from nonadenomas.
    Foti G; Faccioli N; Mantovani W; Malleo G; Manfredi R; Mucelli RP
    Eur J Radiol; 2012 Aug; 81(8):1742-50. PubMed ID: 21602008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Value of Nonenhanced Single-Source Dual-Energy CT for Differentiating Metastases From Adenoma in Adrenal Glands.
    Ju Y; Liu A; Dong Y; Liu Y; Wang H; Sun M; Pu R; Chen A
    Acad Radiol; 2015 Jul; 22(7):834-9. PubMed ID: 25957502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
    Schloetelburg W; Ebert I; Petritsch B; Weng AM; Dischinger U; Kircher S; Buck AK; Bley TA; Deutschbein T; Fassnacht M
    Eur J Endocrinol; 2021 Dec; 186(2):183-193. PubMed ID: 34813495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-method agreement between wash-in and wash-out computed tomography for characterizing hyperattenuating adrenal lesions as adenomas or non-adenomas.
    Kim MJ; Kang KA; Kim CK; Park SY
    Eur Radiol; 2023 Mar; 33(3):2218-2226. PubMed ID: 36173446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.